市場調査レポート：世界の糞便膵臓エラスターゼ試験市場 2028年：糞便膵臓エラスターゼELISAキット、迅速糞便膵臓エラスターゼキット

• 英文タイトル：Global Fecal Pancreatic Elastase Testing Market Insights, Forecast to 2028

Global Fecal Pancreatic Elastase Testing Market Insights, Forecast to 2028「世界の糞便膵臓エラスターゼ試験市場 2028年：糞便膵臓エラスターゼELISAキット、迅速糞便膵臓エラスターゼキット」（市場規模、市場予測）調査レポートです。

• レポートコード：QY2207C3584
• 出版社/出版日：QYResearch / 2022年7月11日
• レポート形態：英文、PDF、107ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療機器

• 販売価格（消費税別）

Single User	￥725,200 (USD4,900)	▷ お問い合わせ
Multi User	￥1,087,800 (USD7,350)	▷ お問い合わせ
Enterprise License	￥1,450,400 (USD9,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

新型コロナウイルス感染症のパンデミックにより、世界の糞便膵臓エラスターゼ試験の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に糞便膵臓エラスターゼ試験の世界市場のxxx％を占める「糞便膵臓エラスターゼELISAキット」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「病院」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。
中国の糞便膵臓エラスターゼ試験の市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパの糞便膵臓エラスターゼ試験市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパの糞便膵臓エラスターゼ試験市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。

糞便膵臓エラスターゼ試験のグローバル主要メーカーには、Laboratory Corporation of America® Holdings、DiaSorin、ScheBo Biotech AG、Immundiagnostik AG、Invivo Healthcare、DRG Instruments GMBH、Verisana Laboratories、BÜHLMANN Laboratories AG、CerTest Biotec S.L.、R-Biopharm AG、American Laboratory Products Company, Ltd.、Vitassay Healthcare, S.L.U.などがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。

糞便膵臓エラスターゼ試験市場は、種類と用途によって区分されます。世界の糞便膵臓エラスターゼ試験市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。

【種類別セグメント】
糞便膵臓エラスターゼELISAキット、迅速糞便膵臓エラスターゼキット

【用途別セグメント】
病院、診断研究所、専門クリニック

【掲載地域】
北米：アメリカ、カナダ
ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア
中南米：メキシコ、ブラジル、アルゼンチン
中東・アフリカ：トルコ、サウジアラビア、UAE

【目次（一部）】

・調査の範囲
- 糞便膵臓エラスターゼ試験製品概要
- 種類別市場（糞便膵臓エラスターゼELISAキット、迅速糞便膵臓エラスターゼキット）
- 用途別市場（病院、診断研究所、専門クリニック）
- 調査の目的
・エグゼクティブサマリー
- 世界の糞便膵臓エラスターゼ試験販売量予測2017-2028
- 世界の糞便膵臓エラスターゼ試験売上予測2017-2028
- 糞便膵臓エラスターゼ試験の地域別販売量
- 糞便膵臓エラスターゼ試験の地域別売上
- 北米市場
- ヨーロッパ市場
- アジア太平洋市場
- 中南米市場
- 中東・アフリカ市場
・メーカーの競争状況
- 主要メーカー別糞便膵臓エラスターゼ試験販売量
- 主要メーカー別糞便膵臓エラスターゼ試験売上
- 主要メーカー別糞便膵臓エラスターゼ試験価格
- 競争状況の分析
- 企業M&A動向
・種類別市場規模（糞便膵臓エラスターゼELISAキット、迅速糞便膵臓エラスターゼキット）
- 糞便膵臓エラスターゼ試験の種類別販売量
- 糞便膵臓エラスターゼ試験の種類別売上
- 糞便膵臓エラスターゼ試験の種類別価格
・用途別市場規模（病院、診断研究所、専門クリニック）
- 糞便膵臓エラスターゼ試験の用途別販売量
- 糞便膵臓エラスターゼ試験の用途別売上
- 糞便膵臓エラスターゼ試験の用途別価格
・北米市場
- 北米の糞便膵臓エラスターゼ試験市場規模（種類別、用途別）
- 主要国別の糞便膵臓エラスターゼ試験市場規模（アメリカ、カナダ）
・ヨーロッパ市場
- ヨーロッパの糞便膵臓エラスターゼ試験市場規模（種類別、用途別）
- 主要国別の糞便膵臓エラスターゼ試験市場規模（ドイツ、フランス、イギリス、イタリア、ロシア）
・アジア太平洋市場
- アジア太平洋の糞便膵臓エラスターゼ試験市場規模（種類別、用途別）
- 主要国別の糞便膵臓エラスターゼ試験市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア）
・中南米市場
- 中南米の糞便膵臓エラスターゼ試験市場規模（種類別、用途別）
- 主要国別の糞便膵臓エラスターゼ試験市場規模（メキシコ、ブラジル、アルゼンチン）
・中東・アフリカ市場
- 中東・アフリカの糞便膵臓エラスターゼ試験市場規模（種類別、用途別）
- 主要国別の糞便膵臓エラスターゼ試験市場規模（トルコ、サウジアラビア）
・企業情報
Laboratory Corporation of America® Holdings、DiaSorin、ScheBo Biotech AG、Immundiagnostik AG、Invivo Healthcare、DRG Instruments GMBH、Verisana Laboratories、BÜHLMANN Laboratories AG、CerTest Biotec S.L.、R-Biopharm AG、American Laboratory Products Company, Ltd.、Vitassay Healthcare, S.L.U.
・産業チェーン及び販売チャネル分析
- 糞便膵臓エラスターゼ試験の産業チェーン分析
- 糞便膵臓エラスターゼ試験の原材料
- 糞便膵臓エラスターゼ試験の生産プロセス
- 糞便膵臓エラスターゼ試験の販売及びマーケティング
- 糞便膵臓エラスターゼ試験の主要顧客
・マーケットドライバー、機会、課題、リスク要因分析
- 糞便膵臓エラスターゼ試験の産業動向
- 糞便膵臓エラスターゼ試験のマーケットドライバー
- 糞便膵臓エラスターゼ試験の課題
- 糞便膵臓エラスターゼ試験の阻害要因
・主な調査結果

Market Analysis and Insights: Global Fecal Pancreatic Elastase Testing Market
Due to the COVID-19 pandemic, the global Fecal Pancreatic Elastase Testing market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, Fecal Pancreatic Elastase ELISA Kits accounting for % of the Fecal Pancreatic Elastase Testing global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Hospitals segment is altered to an % CAGR throughout this forecast period.
China Fecal Pancreatic Elastase Testing market size is valued at US$ million in 2021, while the US and Europe Fecal Pancreatic Elastase Testing are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Fecal Pancreatic Elastase Testing landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
The global key manufacturers of Fecal Pancreatic Elastase Testing include Laboratory Corporation of America® Holdings, DiaSorin, ScheBo Biotech AG, Immundiagnostik AG, Invivo Healthcare, DRG Instruments GMBH, Verisana Laboratories, BÜHLMANN Laboratories AG and CerTest Biotec S.L., etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Global Fecal Pancreatic Elastase Testing Scope and Segment
Fecal Pancreatic Elastase Testing market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Fecal Pancreatic Elastase Testing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Fecal Pancreatic Elastase ELISA Kits
Rapid Fecal Pancreatic Elastase Kits
Segment by Application
Hospitals
Diagnostics Laboratories
Specialty Clinics
By Company
Laboratory Corporation of America® Holdings
DiaSorin
ScheBo Biotech AG
Immundiagnostik AG
Invivo Healthcare
DRG Instruments GMBH
Verisana Laboratories
BÜHLMANN Laboratories AG
CerTest Biotec S.L.
R-Biopharm AG
American Laboratory Products Company, Ltd.
Vitassay Healthcare, S.L.U.
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE

レポート目次

1 Study Coverage
1.1 Fecal Pancreatic Elastase Testing Product Introduction
1.2 Market by Type
1.2.1 Global Fecal Pancreatic Elastase Testing Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Fecal Pancreatic Elastase ELISA Kits
1.2.3 Rapid Fecal Pancreatic Elastase Kits
1.3 Market by Application
1.3.1 Global Fecal Pancreatic Elastase Testing Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospitals
1.3.3 Diagnostics Laboratories
1.3.4 Specialty Clinics
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Fecal Pancreatic Elastase Testing Sales Estimates and Forecasts 2017-2028
2.2 Global Fecal Pancreatic Elastase Testing Revenue Estimates and Forecasts 2017-2028
2.3 Global Fecal Pancreatic Elastase Testing Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Fecal Pancreatic Elastase Testing Sales by Region
2.4.1 Global Fecal Pancreatic Elastase Testing Sales by Region (2017-2022)
2.4.2 Global Sales Fecal Pancreatic Elastase Testing by Region (2023-2028)
2.5 Global Fecal Pancreatic Elastase Testing Revenue by Region
2.5.1 Global Fecal Pancreatic Elastase Testing Revenue by Region (2017-2022)
2.5.2 Global Fecal Pancreatic Elastase Testing Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Fecal Pancreatic Elastase Testing Sales by Manufacturers
3.1.1 Global Top Fecal Pancreatic Elastase Testing Manufacturers by Sales (2017-2022)
3.1.2 Global Fecal Pancreatic Elastase Testing Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Fecal Pancreatic Elastase Testing in 2021
3.2 Global Fecal Pancreatic Elastase Testing Revenue by Manufacturers
3.2.1 Global Fecal Pancreatic Elastase Testing Revenue by Manufacturers (2017-2022)
3.2.2 Global Fecal Pancreatic Elastase Testing Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Fecal Pancreatic Elastase Testing Revenue in 2021
3.3 Global Fecal Pancreatic Elastase Testing Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Fecal Pancreatic Elastase Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Fecal Pancreatic Elastase Testing Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Fecal Pancreatic Elastase Testing Sales by Type
4.1.1 Global Fecal Pancreatic Elastase Testing Historical Sales by Type (2017-2022)
4.1.2 Global Fecal Pancreatic Elastase Testing Forecasted Sales by Type (2023-2028)
4.1.3 Global Fecal Pancreatic Elastase Testing Sales Market Share by Type (2017-2028)
4.2 Global Fecal Pancreatic Elastase Testing Revenue by Type
4.2.1 Global Fecal Pancreatic Elastase Testing Historical Revenue by Type (2017-2022)
4.2.2 Global Fecal Pancreatic Elastase Testing Forecasted Revenue by Type (2023-2028)
4.2.3 Global Fecal Pancreatic Elastase Testing Revenue Market Share by Type (2017-2028)
4.3 Global Fecal Pancreatic Elastase Testing Price by Type
4.3.1 Global Fecal Pancreatic Elastase Testing Price by Type (2017-2022)
4.3.2 Global Fecal Pancreatic Elastase Testing Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Fecal Pancreatic Elastase Testing Sales by Application
5.1.1 Global Fecal Pancreatic Elastase Testing Historical Sales by Application (2017-2022)
5.1.2 Global Fecal Pancreatic Elastase Testing Forecasted Sales by Application (2023-2028)
5.1.3 Global Fecal Pancreatic Elastase Testing Sales Market Share by Application (2017-2028)
5.2 Global Fecal Pancreatic Elastase Testing Revenue by Application
5.2.1 Global Fecal Pancreatic Elastase Testing Historical Revenue by Application (2017-2022)
5.2.2 Global Fecal Pancreatic Elastase Testing Forecasted Revenue by Application (2023-2028)
5.2.3 Global Fecal Pancreatic Elastase Testing Revenue Market Share by Application (2017-2028)
5.3 Global Fecal Pancreatic Elastase Testing Price by Application
5.3.1 Global Fecal Pancreatic Elastase Testing Price by Application (2017-2022)
5.3.2 Global Fecal Pancreatic Elastase Testing Price Forecast by Application (2023-2028)
6 North America
6.1 North America Fecal Pancreatic Elastase Testing Market Size by Type
6.1.1 North America Fecal Pancreatic Elastase Testing Sales by Type (2017-2028)
6.1.2 North America Fecal Pancreatic Elastase Testing Revenue by Type (2017-2028)
6.2 North America Fecal Pancreatic Elastase Testing Market Size by Application
6.2.1 North America Fecal Pancreatic Elastase Testing Sales by Application (2017-2028)
6.2.2 North America Fecal Pancreatic Elastase Testing Revenue by Application (2017-2028)
6.3 North America Fecal Pancreatic Elastase Testing Market Size by Country
6.3.1 North America Fecal Pancreatic Elastase Testing Sales by Country (2017-2028)
6.3.2 North America Fecal Pancreatic Elastase Testing Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Fecal Pancreatic Elastase Testing Market Size by Type
7.1.1 Europe Fecal Pancreatic Elastase Testing Sales by Type (2017-2028)
7.1.2 Europe Fecal Pancreatic Elastase Testing Revenue by Type (2017-2028)
7.2 Europe Fecal Pancreatic Elastase Testing Market Size by Application
7.2.1 Europe Fecal Pancreatic Elastase Testing Sales by Application (2017-2028)
7.2.2 Europe Fecal Pancreatic Elastase Testing Revenue by Application (2017-2028)
7.3 Europe Fecal Pancreatic Elastase Testing Market Size by Country
7.3.1 Europe Fecal Pancreatic Elastase Testing Sales by Country (2017-2028)
7.3.2 Europe Fecal Pancreatic Elastase Testing Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Fecal Pancreatic Elastase Testing Market Size by Type
8.1.1 Asia Pacific Fecal Pancreatic Elastase Testing Sales by Type (2017-2028)
8.1.2 Asia Pacific Fecal Pancreatic Elastase Testing Revenue by Type (2017-2028)
8.2 Asia Pacific Fecal Pancreatic Elastase Testing Market Size by Application
8.2.1 Asia Pacific Fecal Pancreatic Elastase Testing Sales by Application (2017-2028)
8.2.2 Asia Pacific Fecal Pancreatic Elastase Testing Revenue by Application (2017-2028)
8.3 Asia Pacific Fecal Pancreatic Elastase Testing Market Size by Region
8.3.1 Asia Pacific Fecal Pancreatic Elastase Testing Sales by Region (2017-2028)
8.3.2 Asia Pacific Fecal Pancreatic Elastase Testing Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Fecal Pancreatic Elastase Testing Market Size by Type
9.1.1 Latin America Fecal Pancreatic Elastase Testing Sales by Type (2017-2028)
9.1.2 Latin America Fecal Pancreatic Elastase Testing Revenue by Type (2017-2028)
9.2 Latin America Fecal Pancreatic Elastase Testing Market Size by Application
9.2.1 Latin America Fecal Pancreatic Elastase Testing Sales by Application (2017-2028)
9.2.2 Latin America Fecal Pancreatic Elastase Testing Revenue by Application (2017-2028)
9.3 Latin America Fecal Pancreatic Elastase Testing Market Size by Country
9.3.1 Latin America Fecal Pancreatic Elastase Testing Sales by Country (2017-2028)
9.3.2 Latin America Fecal Pancreatic Elastase Testing Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
9.3.6 Colombia
10 Middle East and Africa
10.1 Middle East and Africa Fecal Pancreatic Elastase Testing Market Size by Type
10.1.1 Middle East and Africa Fecal Pancreatic Elastase Testing Sales by Type (2017-2028)
10.1.2 Middle East and Africa Fecal Pancreatic Elastase Testing Revenue by Type (2017-2028)
10.2 Middle East and Africa Fecal Pancreatic Elastase Testing Market Size by Application
10.2.1 Middle East and Africa Fecal Pancreatic Elastase Testing Sales by Application (2017-2028)
10.2.2 Middle East and Africa Fecal Pancreatic Elastase Testing Revenue by Application (2017-2028)
10.3 Middle East and Africa Fecal Pancreatic Elastase Testing Market Size by Country
10.3.1 Middle East and Africa Fecal Pancreatic Elastase Testing Sales by Country (2017-2028)
10.3.2 Middle East and Africa Fecal Pancreatic Elastase Testing Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Laboratory Corporation of America® Holdings
11.1.1 Laboratory Corporation of America® Holdings Corporation Information
11.1.2 Laboratory Corporation of America® Holdings Overview
11.1.3 Laboratory Corporation of America® Holdings Fecal Pancreatic Elastase Testing Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Laboratory Corporation of America® Holdings Fecal Pancreatic Elastase Testing Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Laboratory Corporation of America® Holdings Recent Developments
11.2 DiaSorin
11.2.1 DiaSorin Corporation Information
11.2.2 DiaSorin Overview
11.2.3 DiaSorin Fecal Pancreatic Elastase Testing Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 DiaSorin Fecal Pancreatic Elastase Testing Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 DiaSorin Recent Developments
11.3 ScheBo Biotech AG
11.3.1 ScheBo Biotech AG Corporation Information
11.3.2 ScheBo Biotech AG Overview
11.3.3 ScheBo Biotech AG Fecal Pancreatic Elastase Testing Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 ScheBo Biotech AG Fecal Pancreatic Elastase Testing Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 ScheBo Biotech AG Recent Developments
11.4 Immundiagnostik AG
11.4.1 Immundiagnostik AG Corporation Information
11.4.2 Immundiagnostik AG Overview
11.4.3 Immundiagnostik AG Fecal Pancreatic Elastase Testing Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Immundiagnostik AG Fecal Pancreatic Elastase Testing Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Immundiagnostik AG Recent Developments
11.5 Invivo Healthcare
11.5.1 Invivo Healthcare Corporation Information
11.5.2 Invivo Healthcare Overview
11.5.3 Invivo Healthcare Fecal Pancreatic Elastase Testing Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Invivo Healthcare Fecal Pancreatic Elastase Testing Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Invivo Healthcare Recent Developments
11.6 DRG Instruments GMBH
11.6.1 DRG Instruments GMBH Corporation Information
11.6.2 DRG Instruments GMBH Overview
11.6.3 DRG Instruments GMBH Fecal Pancreatic Elastase Testing Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 DRG Instruments GMBH Fecal Pancreatic Elastase Testing Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 DRG Instruments GMBH Recent Developments
11.7 Verisana Laboratories
11.7.1 Verisana Laboratories Corporation Information
11.7.2 Verisana Laboratories Overview
11.7.3 Verisana Laboratories Fecal Pancreatic Elastase Testing Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Verisana Laboratories Fecal Pancreatic Elastase Testing Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Verisana Laboratories Recent Developments
11.8 BÜHLMANN Laboratories AG
11.8.1 BÜHLMANN Laboratories AG Corporation Information
11.8.2 BÜHLMANN Laboratories AG Overview
11.8.3 BÜHLMANN Laboratories AG Fecal Pancreatic Elastase Testing Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 BÜHLMANN Laboratories AG Fecal Pancreatic Elastase Testing Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 BÜHLMANN Laboratories AG Recent Developments
11.9 CerTest Biotec S.L.
11.9.1 CerTest Biotec S.L. Corporation Information
11.9.2 CerTest Biotec S.L. Overview
11.9.3 CerTest Biotec S.L. Fecal Pancreatic Elastase Testing Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 CerTest Biotec S.L. Fecal Pancreatic Elastase Testing Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 CerTest Biotec S.L. Recent Developments
11.10 R-Biopharm AG
11.10.1 R-Biopharm AG Corporation Information
11.10.2 R-Biopharm AG Overview
11.10.3 R-Biopharm AG Fecal Pancreatic Elastase Testing Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 R-Biopharm AG Fecal Pancreatic Elastase Testing Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 R-Biopharm AG Recent Developments
11.11 American Laboratory Products Company, Ltd.
11.11.1 American Laboratory Products Company, Ltd. Corporation Information
11.11.2 American Laboratory Products Company, Ltd. Overview
11.11.3 American Laboratory Products Company, Ltd. Fecal Pancreatic Elastase Testing Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 American Laboratory Products Company, Ltd. Fecal Pancreatic Elastase Testing Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 American Laboratory Products Company, Ltd. Recent Developments
11.12 Vitassay Healthcare, S.L.U.
11.12.1 Vitassay Healthcare, S.L.U. Corporation Information
11.12.2 Vitassay Healthcare, S.L.U. Overview
11.12.3 Vitassay Healthcare, S.L.U. Fecal Pancreatic Elastase Testing Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 Vitassay Healthcare, S.L.U. Fecal Pancreatic Elastase Testing Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Vitassay Healthcare, S.L.U. Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Fecal Pancreatic Elastase Testing Industry Chain Analysis
12.2 Fecal Pancreatic Elastase Testing Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Fecal Pancreatic Elastase Testing Production Mode & Process
12.4 Fecal Pancreatic Elastase Testing Sales and Marketing
12.4.1 Fecal Pancreatic Elastase Testing Sales Channels
12.4.2 Fecal Pancreatic Elastase Testing Distributors
12.5 Fecal Pancreatic Elastase Testing Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Fecal Pancreatic Elastase Testing Industry Trends
13.2 Fecal Pancreatic Elastase Testing Market Drivers
13.3 Fecal Pancreatic Elastase Testing Market Challenges
13.4 Fecal Pancreatic Elastase Testing Market Restraints
14 Key Findings in The Global Fecal Pancreatic Elastase Testing Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer